Article
Impact of CYBA genotypes on severity and progression of multiple sclerosis.
European journal of neurology - 1 May 2022
Törnell Andreas, Kiffin Roberta, Haghighi Sara, Mossberg Natalia, Andersen Oluf, Hellstrand Kristoffer, Martner Anna
Abstract excerpt
BACKGROUND AND PURPOSE: The NOX2 enzyme of myeloid cells generates reactive oxygen species (ROS) that have been implicated in the pathology of multiple sclerosis (MS). We aimed to determine the impact of genetic variation within CYBA, which encodes the functional CYBA/p22phox subunit of NOX2, on MS severity and progression. METHODS: One hundred three MS patients with up to 49 (median = 17) years follow-up time...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
